Jennifer Michaelson
Chief Tech/Sci/R&D Officer at CULLINAN THERAPEUTICS, INC.
Net worth: 2 M $ as of 30/04/2024
Jennifer Michaelson active positions
Companies | Position | Start | End |
---|---|---|---|
CULLINAN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/06/2023 | - |
Corporate Officer/Principal | 01/01/2018 | 01/06/2023 |
Career history of Jennifer Michaelson
Former positions of Jennifer Michaelson
Companies | Position | Start | End |
---|---|---|---|
Celsius Therapeutics, Inc.
Celsius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/07/2017 | 01/12/2017 |
JOUNCE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/09/2012 | 01/07/2017 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2018 | - |
Training of Jennifer Michaelson
Princeton University | Undergraduate Degree |
Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Statistics
International
United States | 7 |
Operational
Corporate Officer/Principal | 4 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectoral
Consumer Services | 3 |
Health Technology | 3 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
CULLINAN THERAPEUTICS, INC. | Health Technology |
Private companies | 3 |
---|---|
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Finance |
Jounce Therapeutics, Inc.
Jounce Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA. | Commercial Services |
Celsius Therapeutics, Inc.
Celsius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Jennifer Michaelson
- Experience